Form 4: Macrogenics Director Jay Philip Siegel Reports Stock Transactions

Director Jay Philip Siegel reports acquisition and disposal of Macrogenics Inc. stock and derivative securities.

Summary

• On May 20, 2025, Jay Philip Siegel, a director of Macrogenics Inc. (MGNX), reported transactions involving the company's stock.
• Siegel disposed of 6,500 shares of common stock.
• Siegel also acquired 6,500 shares through the vesting of restricted stock units (RSUs).
• On May 21, 2025, Siegel acquired 3,750 restricted stock units and options to buy 22,000 shares of common stock at $1.49 per share.
• The RSUs will vest one year from the grant date or the day prior to the next annual meeting, if earlier.
• The stock options vest in monthly increments over one year from the grant date.

Sentiment

Score: 5

Explanation: This is a neutral report of insider trading activity, neither particularly positive nor negative.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the trading activities of company directors. It is standard practice for directors to receive stock options and RSUs as part of their compensation.

Stakeholder Impact

• The transactions could have a minor impact on shareholders by signaling management's view of the company's prospects, although these transactions are likely part of a pre-determined compensation plan.

Key Dates

Keywords

Macrogenics, MGNX, Director, Insider Trading, Form 4, Stock Options, Restricted Stock Units, Equity, Securities